Thong Vu — 16 Patents at AbbVie

Thong Vu has been granted 16 US patents while listed as an inventor at AbbVie. The first was granted in 2003 and the most recent in October 2025. Thong Vu ranks #284,196 of 4,157,543 US inventors in our database (top 6.8%). Patent records list Thong Vu in Garden Grove, CA, US.

Patents per Year

Issued Patents All Time

Showing 1–16 of 16 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
D1100090	Golf club head	Wee Joung Kim	2025-10-28
9920013	2,5-dioxoimidazolidin-1-yl-3-urea derivatives as formyl peptide modulators	Richard L. Beard, Vidyasagar Vuligonda, Michael E. Garst	2018-03-20
9868700	Carbamoyl hydrazine derivatives as formyl peptide modulators	Vidyasagar Vuligonda, Veena Viswanath, John E. Donello, Richard L. Beard	2018-01-16
9663457	Carbamoyl hydrazine derivatives as formyl peptide modulators	Richard L. Beard, Vidyasagar Vuligonda, Veena Viswanath, John E. Donello	2017-05-30
9604934	Urea hydantoin derivatives as formyl peptide modulators	Richard L. Beard, Vidyasagar Vuligonda, Michael E. Garst	2017-03-28
9090624	Aromatic bycyclic derivatives as CXCR4 receptor modulators	Vidyasagar Vuligonda, Richard L. Beard, John E. Donello, Gerard A. Rodrigues, Veena Viswanath +1 more	2015-07-28
8846760	Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators	Richard L. Beard, Vidyasagar Vuligonda, John E. Donello, Veena Viswanath, Michael E. Garst	2014-09-30	$56,591,000
8653299	Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators	Vidyasagar Vuligonda, Richard L. Beard, John E. Donello, Veena Viswanath, Michael E. Garst	2014-02-18	$36,661,000
8492556	2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators	Richard L. Beard, Vidyasagar Vuligonda, John E. Donello, Veena Viswanath, Michael E. Garst	2013-07-23	$19,301,000
8440684	Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (FPRL-1) receptor modulators	Richard L. Beard, Vidyasagar Vuligonda, John E. Donello, Veena Viswanath, Michael E. Garst	2013-05-14	$25,223,000
8193203	Bicyclic compounds having activity at the CXCR4 receptor	Richard L. Beard, Tien T. Duong, Vidyasagar Vuligonda, John E. Donello, Michael E. Garst +1 more	2012-06-05	$51,738,000
7638648	Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same	Jayasree Vasudevan, Liming Wang, Xiaoxia Liu, Kwok Yin Tsang, Ling Li +5 more	2009-12-29	$71,292,000
7468391	Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B	Jayasree Vasudevan, Rong Yang, Liming Wang, Xiaoxia Liu, Kwok Yin Tsang +5 more	2008-12-23	$17,829,000
7226951	Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same	Jayasree Vasudevan, Liming Wang, Xiaoxia Liu, Kwok Yin Tsang, Ling Li +5 more	2007-06-05	$80,992,000
7026487	Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity	Richard L. Beard, Diana F. Colon, Vidyasagar Vuligonda, Roshantha A. Chandraratna	2006-04-11	$77,013,000
6613917	Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity	Richard L. Beard, Diana F. Colon, Vidyasagar Vuligonda, Roshantha A. Chandraratna	2003-09-02	$67,555,000

Thong Vu — 16 Patents

Patents per Year

Issued Patents All Time

Patent Widget